Work

Female Syrian hamster analyses of bremelanotide, a US FDA approved drug for the treatment of female hypoactive sexual desire disorder

Year: 2025

Type: article

Source: Neuropharmacology

DOI: 10.1016/j.neuropharm.2025.110299

Authors: Johnathan M. Borland, Abigail L. Kohut-Jackson, Anna C. Peyla, Megan AL. Hall, Paul G. Mermelstein, Robert L. Meisel

Institutions: University of Minnesota, Saint Louis University

Language: English

Topic: Neurotransmitter Receptor Influence on Behavior

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: University of Minnesota, National Institute of Mental Health and Neurosciences, National Institutes of Health, National Institute of Mental Health, National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: Neurobiology of Female Sexual Desire, G7481015223, Synaptic plasticity underlying sex differences in aggression reward

OpenAlex ID: W4406165963

FWCI: 1.522

Cites: 69

Cited by: 5

Related to: 10